Compound ID | 1010
2-Nitroimidazole derivatives
Class: Nitroimidazole
| Details of activity: | Some derivatives show limitted activity against gram + and - bacteria. Parent molecule is currently used in tumour therapeutics. |
| Institute where first reported: | Hofimann-La Roche Inc |
| Year first mentioned: | 1967 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: | https://www.ncbi.nlm.nih.gov/pubmed/5596183 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.